Variant report
Variant | esv3412283 |
---|---|
Chromosome Location | chr8:124202171-124206869 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:119)
- CpG islands (count:0)
- Chromatin interactive region (count:12)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF3 | chr8:124203038-124203367 | K562 | blood: | n/a | n/a |
2 | BHLHE40 | chr8:124203099-124203360 | K562 | blood: | n/a | n/a |
3 | CEBPB | chr8:124206589-124206732 | IMR90 | lung: | n/a | chr8:124206684-124206695 |
4 | CEBPB | chr8:124206587-124206811 | A549 | lung: | n/a | chr8:124206684-124206695 |
5 | CEBPB | chr8:124206597-124206815 | HepG2 | liver: | n/a | chr8:124206684-124206695 |
6 | CTCF | chr8:124204880-124205030 | GM12869 | blood: | n/a | chr8:124204998-124205011 chr8:124204887-124204895 |
7 | CTCF | chr8:124204953-124205083 | K562 | blood: | n/a | chr8:124204998-124205011 |
8 | CTCF | chr8:124203520-124203670 | HMEC | breast: | n/a | n/a |
9 | CTCF | chr8:124203500-124203650 | MCF-7 | breast: | n/a | n/a |
10 | CTCF | chr8:124204920-124205070 | HBMEC | blood vessel: | n/a | chr8:124204998-124205011 |
11 | CTCF | chr8:124204846-124205123 | K562 | blood: | n/a | chr8:124204998-124205011 chr8:124204887-124204895 |
12 | CTCF | chr8:124204926-124205111 | Hela-S3 | cervix: | n/a | chr8:124204998-124205011 |
13 | CTCF | chr8:124203594-124203773 | K562 | blood: | n/a | n/a |
14 | CTCF | chr8:124203547-124203699 | HepG2 | liver: | n/a | n/a |
15 | CTCF | chr8:124204880-124205030 | BE2_C | brain: | n/a | chr8:124204998-124205011 chr8:124204887-124204895 |
16 | CTCF | chr8:124204940-124205090 | HEEpiC | esophagus: | n/a | chr8:124204998-124205011 |
17 | CTCF | chr8:124204880-124205030 | HepG2 | liver: | n/a | chr8:124204998-124205011 chr8:124204887-124204895 |
18 | CTCF | chr8:124204980-124205130 | HCPEpiC | choroid plexus: | n/a | chr8:124204998-124205011 |
19 | CTCF | chr8:124204974-124205040 | GM12891 | blood: | n/a | chr8:124204998-124205011 |
20 | CTCF | chr8:124204840-124204990 | HEEpiC | esophagus: | n/a | chr8:124204887-124204895 |
21 | CTCF | chr8:124204863-124205225 | K562 | blood: | n/a | chr8:124204998-124205011 chr8:124204887-124204895 |
22 | CTCF | chr8:124204995-124205037 | ProgFib | skin: | n/a | chr8:124204998-124205011 |
23 | CTCF | chr8:124204971-124205074 | Fibrobl | skin: | n/a | chr8:124204998-124205011 |
24 | CTCF | chr8:124205006-124205044 | GM19238 | blood: | n/a | n/a |
25 | CTCF | chr8:124204920-124205070 | Hela-S3 | cervix: | n/a | chr8:124204998-124205011 |
26 | CTCF | chr8:124204880-124205030 | SAEC | small airway: | n/a | chr8:124204998-124205011 chr8:124204887-124204895 |
27 | CTCF | chr8:124205005-124205073 | LNCaP | prostate: | n/a | n/a |
28 | CTCF | chr8:124203020-124203170 | GM12864 | blood: | n/a | n/a |
29 | CTCF | chr8:124204960-124205110 | MCF-7 | breast: | n/a | chr8:124204998-124205011 |
30 | CTCF | chr8:124204979-124205040 | H1-hESC | embryonic stem cell: | n/a | chr8:124204998-124205011 |
31 | CTCF | chr8:124204864-124205093 | K562 | blood: | n/a | chr8:124204998-124205011 chr8:124204887-124204895 |
32 | CTCF | chr8:124204960-124205110 | SAEC | small airway: | n/a | chr8:124204998-124205011 |
33 | CTCF | chr8:124204927-124205064 | HepG2 | liver: | n/a | chr8:124204998-124205011 |
34 | CTCF | chr8:124204920-124205070 | HMEC | breast: | n/a | chr8:124204998-124205011 |
35 | CTCF | chr8:124204934-124205098 | MCF-7 | breast: | n/a | chr8:124204998-124205011 |
36 | CTCF | chr8:124203600-124203750 | GM12872 | blood: | n/a | n/a |
37 | CTCF | chr8:124203582-124203705 | HepG2 | liver: | n/a | n/a |
38 | CTCF | chr8:124203373-124203829 | MCF-7 | breast: | n/a | n/a |
39 | CTCF | chr8:124204900-124205050 | HepG2 | liver: | n/a | chr8:124204998-124205011 |
40 | CTCF | chr8:124204943-124205052 | HepG2 | liver: | n/a | chr8:124204998-124205011 |
41 | CTCF | chr8:124203594-124203705 | Hela-S3 | cervix: | n/a | n/a |
42 | CTCF | chr8:124204925-124205112 | MCF-7 | breast: | n/a | chr8:124204998-124205011 |
43 | CTCF | chr8:124203599-124203703 | MCF-7 | breast: | n/a | n/a |
44 | CTCF | chr8:124204960-124205110 | GM12864 | blood: | n/a | chr8:124204998-124205011 |
45 | CTCF | chr8:124204923-124205117 | MCF-7 | breast: | n/a | chr8:124204998-124205011 |
46 | CTCF | chr8:124204980-124205130 | WERI-Rb-1 | eye: | n/a | chr8:124204998-124205011 |
47 | CTCF | chr8:124204936-124205103 | MCF-7 | breast: | n/a | chr8:124204998-124205011 |
48 | CTCF | chr8:124204900-124205050 | HCPEpiC | choroid plexus: | n/a | chr8:124204998-124205011 |
49 | CTCF | chr8:124204913-124205116 | MCF-7 | breast: | n/a | chr8:124204998-124205011 |
50 | CTCF | chr8:124204967-124205074 | NHEK | skin: | n/a | chr8:124204998-124205011 |
No data |
(count:12 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:124172226..124173291-chr8:124203205..124204142,6 | MCF-7 | breast: | |
2 | chr8:124172170..124173373-chr8:124203108..124203740,5 | MCF-7 | breast: | |
3 | chr8:124034586..124035350-chr8:124203347..124204148,2 | MCF-7 | breast: | |
4 | chr8:124205722..124208237-chr8:124217531..124219104,2 | K562 | blood: | |
5 | chr8:124202911..124204464-chr8:124210784..124212515,2 | K562 | blood: | |
6 | chr8:124202642..124205088-chr8:124211959..124213771,2 | MCF-7 | breast: | |
7 | chr8:124193731..124198397-chr8:124202096..124205086,5 | MCF-7 | breast: | |
8 | chr8:124197444..124199510-chr8:124205893..124207940,2 | MCF-7 | breast: | |
9 | chr8:124202410..124205099-chr8:124250791..124252752,2 | K562 | blood: | |
10 | chr8:124202299..124204634-chr8:124227331..124230067,2 | K562 | blood: | |
11 | chr8:124202196..124205513-chr8:124205556..124208969,4 | K562 | blood: | |
12 | chr8:124205866..124208638-chr8:124223387..124226315,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000253410 | TF binding region |
ENSG00000253410 | chromatin interactions |
ENSG00000266324 | chromatin interactions |
ENSG00000147689 | chromatin interactions |
ENSG00000189376 | chromatin interactions |
ENSG00000253258 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs11783554 | chr8:124202184-124202185 | Weak transcription Active TSS Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs540428370 | chr8:124202210-124202211 | Weak transcription Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
3 | rs11779903 | chr8:124202219-124202220 | Weak transcription Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
4 | rs11779971 | chr8:124202236-124202237 | Weak transcription Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs367759173 | chr8:124202261-124202262 | Weak transcription Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
6 | rs529186579 | chr8:124202293-124202294 | Weak transcription Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
7 | rs533539587 | chr8:124202336-124202337 | Weak transcription Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
8 | rs140667630 | chr8:124202352-124202353 | Weak transcription Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
9 | rs186538036 | chr8:124202419-124202420 | Weak transcription Strong transcription Genic enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
10 | rs56070700 | chr8:124202421-124202422 | Weak transcription Strong transcription Genic enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
11 | rs531443273 | chr8:124202524-124202525 | Weak transcription Strong transcription Genic enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
12 | rs375633053 | chr8:124202525-124202526 | Weak transcription Strong transcription Genic enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
13 | rs558494156 | chr8:124202526-124202527 | Weak transcription Strong transcription Genic enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
14 | rs191344314 | chr8:124202570-124202571 | Weak transcription Strong transcription Genic enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
15 | rs372733145 | chr8:124202588-124202589 | Weak transcription Strong transcription Genic enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
16 | rs182643274 | chr8:124202651-124202652 | Weak transcription Strong transcription Genic enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
17 | rs7812683 | chr8:124202659-124202660 | Weak transcription Strong transcription Genic enhancers | Chromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs567254834 | chr8:124202668-124202669 | Weak transcription Strong transcription Genic enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
19 | rs112663814 | chr8:124202693-124202694 | Weak transcription Strong transcription Genic enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
20 | rs150172330 | chr8:124202705-124202706 | Weak transcription Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
21 | rs536515552 | chr8:124202768-124202769 | Weak transcription Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
22 | rs138618040 | chr8:124202903-124202904 | Enhancers Weak transcription Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
23 | rs544199971 | chr8:124202973-124202974 | Enhancers Weak transcription Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
24 | rs576319998 | chr8:124202998-124202999 | Enhancers Weak transcription Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
25 | rs545489342 | chr8:124203074-124203075 | Weak transcription Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
26 | rs559142902 | chr8:124203148-124203149 | Weak transcription Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
27 | rs572565763 | chr8:124203161-124203162 | Weak transcription Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
28 | rs540468142 | chr8:124203186-124203187 | Weak transcription Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
29 | rs369511248 | chr8:124203187-124203188 | Weak transcription Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
30 | rs114369657 | chr8:124203203-124203204 | Weak transcription Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
31 | rs7833092 | chr8:124203215-124203216 | Weak transcription Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 5 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs542523715 | chr8:124203225-124203226 | Weak transcription Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
33 | rs149299969 | chr8:124203226-124203227 | Weak transcription Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
34 | rs551347766 | chr8:124203251-124203252 | Weak transcription Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
35 | rs34947160 | chr8:124203307-124203308 | Weak transcription Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 5 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs527361416 | chr8:124203322-124203323 | Weak transcription Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
37 | rs563605443 | chr8:124203393-124203394 | Weak transcription Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
38 | rs192167009 | chr8:124203434-124203435 | Weak transcription Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
39 | rs147402059 | chr8:124203508-124203509 | Weak transcription Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
40 | rs7003842 | chr8:124203514-124203515 | Weak transcription Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 5 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs564458619 | chr8:124203515-124203516 | Weak transcription Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
42 | rs75131087 | chr8:124203536-124203537 | Weak transcription Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
43 | rs570327220 | chr8:124203537-124203538 | Weak transcription Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
44 | rs183419492 | chr8:124203544-124203545 | Weak transcription Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
45 | rs558978503 | chr8:124203593-124203594 | Weak transcription Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
46 | rs572601048 | chr8:124203641-124203642 | Weak transcription Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
47 | rs17377283 | chr8:124203663-124203664 | Weak transcription Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 5 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs139189774 | chr8:124203696-124203697 | Weak transcription Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
49 | rs573705966 | chr8:124203705-124203706 | Weak transcription Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
50 | rs542803504 | chr8:124203718-124203719 | Weak transcription Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastric cancer | 17908304 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Developmental delay | 21147756 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Papillary thyroid cancer | 17515504 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Breast cancer | 20932292 | CNVD |
Gastric cancer | 22539939 | CNVD |
Breast cancer | 22056952 | CNVD |
Langer-Giedion syndrome | 16773131 | CNVD |
Lung cancer | 16740712 | CNVD |
Mental retardation | 16773131 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Langer-Giedion syndrome | 22470819 | CNVD |
Cornelia de Lange syndrome | 24599119 | CNVD |
Gastric cancer | 21528007 | CNVD |
Breast cancer | 22532251 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21129771 | CNVD |
benign familial neonatal convulsions | 18472482 | CNVD |
Breast cancer | 16417655 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21183584 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Breast cancer | 20814816 | CNVD |
Colorectal cancer | 22486879 | CNVD |
Breast cancer | 17908964 | CNVD |
Colorectal cancer | 20031965 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Ovarian cancer | 17908964 | CNVD |
Ovarian cancer | 20031965 | CNVD |
Prostate cancer | 20031965 | CNVD |
Non-small cell lung cancer | 17643093 | CNVD |
Prostate cancer | 19242612 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Breast cancer | 16397240 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Breast cancer | 21364760 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Acute myeloid leukemia | 17268525 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Oral squamous cell carcinoma | 21853135 | CNVD |
Breast cancer | 21611746 | CNVD |
Cancer | 20164919 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
Gastric cancer | 22014070 | CNVD |
Breast cancer | 22522925 | CNVD |
Prostate cancer | 22341455 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:124193400-124241200 | Weak transcription | Right Atrium | heart |
2 | chr8:124199800-124206400 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
3 | chr8:124199800-124216600 | Strong transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
4 | chr8:124201000-124205200 | Genic enhancers | K562 | blood |
5 | chr8:124201400-124202200 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr8:124201600-124202800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
7 | chr8:124201600-124202800 | Weak transcription | HMEC | breast |
8 | chr8:124201600-124203000 | Weak transcription | Hela-S3 | cervix |
9 | chr8:124201600-124205000 | Weak transcription | Esophagus | oesophagus |
10 | chr8:124201600-124212600 | Strong transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
11 | chr8:124201600-124216000 | Strong transcription | NHEK | skin |
12 | chr8:124201600-124216800 | Strong transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
13 | chr8:124202200-124203400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr8:124202800-124203000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
15 | chr8:124202800-124211600 | Strong transcription | HMEC | breast |
16 | chr8:124203000-124205200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
17 | chr8:124203000-124206200 | Genic enhancers | Hela-S3 | cervix |
18 | chr8:124204400-124205800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
19 | chr8:124205000-124205200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
20 | chr8:124205000-124205200 | ZNF genes & repeats | Esophagus | oesophagus |
21 | chr8:124205000-124205200 | Enhancers | Gastric | stomach |
22 | chr8:124205000-124205400 | Enhancers | Pancreas | Pancrea |
23 | chr8:124205000-124205800 | Enhancers | Fetal Muscle Trunk | muscle |
24 | chr8:124205200-124205400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
25 | chr8:124205200-124209000 | Strong transcription | K562 | blood |
26 | chr8:124205200-124209200 | Weak transcription | Esophagus | oesophagus |
27 | chr8:124205200-124217600 | Weak transcription | Gastric | stomach |
28 | chr8:124205400-124209200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
29 | chr8:124206000-124206600 | Enhancers | Adipose Nuclei | Adipose |
30 | chr8:124206200-124215200 | Strong transcription | Hela-S3 | cervix |
31 | chr8:124206600-124207200 | Weak transcription | Adipose Nuclei | Adipose |